Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: Impact of autologous hematopoietic stem cell transplantation

Archives of Dermatology

Volumn 146, Issue 6, 2010, Pages 615-623

  Barete, Stéphane ^a   Mouawad, Roger ^b   Choquet, Sylvain ^b   Viala, Karine ^b   Leblond, Véronique ^b   Musset, Lucile ^b   Amoura, Zahir ^b   Khayat, David ^b   Francès, Camille ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; MELPHALAN; VASCULOTROPIN;

ACROCYANOSIS; ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; HEMANGIOMA; HUMAN; HYPERPIGMENTATION; HYPERTRICHOSIS; LIPOATROPHY; MALE; NAIL COLOR DEFECT; POEMS SYNDROME; PRIORITY JOURNAL; SKIN MANIFESTATION; SKINFOLD;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; POEMS SYNDROME; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN; TRANSPLANTATION, AUTOLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77953840971     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.100     Document Type: Article

References (30)

1. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome: report on two cases and a review of the literature. Medicine (Baltimore). 1980;59(4):311-322.
2. Crow RS. Peripheral neuritis in myelomatosis. Br Med J. 1956;2(4996):802-804.
3. Dispenzieri A. POEMS syndrome. Hematology Am Soc Hematol Educ Program. 2005:360-367.
4. Gherardi R, Zuber M, Viard JP. Dysglobulinemic neuropathies [in French]. Rev Neurol (Paris). 1988;144(6-7):391-408.
5. Iwashita H, Ohnishi A, Asada M, Kanazawa Y, Kuroiwa Y. Polyneuropathy, skin hyperpigmentation, edema, and hypertrichosis in localized osteosclerotic myeloma. Neurology. 1977;27(7):675-681. (Pubitemid 8145798)
6. Mineta M, Hatori M, Sano H, et al. Recurrent Crow-Fukase syndrome associated with increased serum levels of vascular endothelial growth factor: a case report and review of the literature. Tohoku J Exp Med. 2006;210(3):269-277.
7. Scarlato M, Previtali SC, Carpo M, et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain. 2005;128(pt 8):1911-1920.
8. Watanabe O, Maruyama I, Arimura K, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve. 1998;21(11):1390-1397.
9. Atkinson S, Fox SB. Vascular endothelial growth factor (VEGF)-A and plateletderived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing. J Pathol. 2004;203(2):721-728.
10. Detmar M. The role of VEGF and thrombospondins in skin angiogenesis. J Dermatol Sci. 2000;24(suppl 1):S78-S84.
11. Distler O, Del Rosso A, Giacomelli R, et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res. 2002;4(6):R11. doi:10.1186/ar596.
12. Kozlowska U, Blume-Peytavi U, Kodelja V, et al. Expression of vascular endothelial growth factor (VEGF) in various compartments of the human hair follicle. Arch Dermatol Res. 1998;290(12):661-668.
13. Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E. Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma. Med Oncol. 2008;25(4):431-436.
14. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101(7):2496-2506.
15. Viala K, Renie L, Maisonobe T, et al. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain. 2004;127(pt 9):2010-2017.
16. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology. 1984;34(6):712-720. (Pubitemid 14107067)
17. Singh D, Wadhwa J, Kumar L, Raina V, Agarwal A, Kochupillai V. POEMS syndrome: experience with fourteen cases. Leuk Lymphoma. 2003;44(10):1749-1752.
18. Soubrier MJ, Dubost JJ, Sauvezie BJ; French Study Group on POEMS Syndrome. POEMS syndrome: a study of 25 cases and a review of the literature. Am J Med. 1994;97(6):543-553.
19. Takatsuki K, Sanada I. Plasma cell dyscrasia with polyneuropathy and endocrine disorder: clinical and laboratory features of 109 reported cases. Jpn J Clin Oncol. 1983;13(3):543-555.
20. Silberman J, Lonial S. Review of peripheral neuropathy in plasma cell disorders. Hematol Oncol. 2008;26(2):55-65.
21. Dispenzieri A. POEMS syndrome. Blood Rev. 2007;21(6):285-299.
22. Doffoel-Hantz V, Jaccard A, Sparsa A, et al. Bevacizumab therapy for POEMS syndrome [in French]. Ann Dermatol Venereol. 2008;135(4):320-321.
23. Solomons RE, Gibbs DD. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes: the POEMS syndrome. J R Soc Med. 1982;75(7):553-555.
24. Vourc'h-Jourdain M, Clairand R, Masseau A, Barbarot S, Hamidou M. Partial lipodystrophy and POEMS syndrome: a case report [in French]. Ann Dermatol Venereol. 2008;135(11):773-775.
25. Stankov MV, Behrens GM. HIV-therapy associated lipodystrophy: experimental and clinical evidence for the pathogenesis and treatment. Endocr Metab Immune Disord Drug Targets. 2007;7(4):237-249.
26. Colaco SM, Miller T, Ruben BS, Fogarty PF, Fox LP. IgM-λ paraproteinemia with associated cutaneous lymphoplasmacytic infiltrate in a patient who meets diagnostic criteria for POEMS syndrome. J Am Acad Dermatol. 2008;58(4):671-675.
27. Dursun B, Artac M, Varan HI, Akkaya BK, Karpuzoglu G, Suleymanlar G. An atypical case of POEMS syndrome with IgG kappaMprotein and end stage renal failure. Int Urol Nephrol. 2005;37(3):581-585.
28. Morrow JS, Schaefer EJ, Huston DP, Rosen SW. POEMS syndrome: studies in a patient with an IgGκ M protein but no polyneuropathy. Arch Intern Med. 1982;142(6):1231-1234.
29. Romas E, Storey E, Ayers M, Byrne E. Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin change (POEMS) syndrome with IgG kappa paraproteinemia. Pathology. 1992;24(3):217-220.
30. Sethi S, Tageja N, Arabi H, Penumetcha R. Lenalidomide therapy in a rare case of POEMS syndrome with kappa restriction. South Med J. 2009;102(10):1092- 1093.